Bridging Global Health Disparities in Rare Disease Drug Development

Rare diseases know no borders—but access to life-changing treatments remains unequal across the world. In regions with limited healthcare resources, barriers such as cost, infrastructure, and regulatory pathways can make it even harder for patients to receive the therapies they desperately need.

In this expert video, David Wesche, MD, PhD shares powerful insights on how global health disparities impact rare disease drug development—and the strategies needed to ensure equitable access worldwide.